Lactic acidosis is a dangerous buildup of lactic acid in the blood that can occur as a rare side effect of metformin, the most commonly prescribed medication for type 2 diabetes. Known clinically as metformin-associated lactic acidosis (MALA), it affects fewer than 10 people per 100,000 patient-years of metformin use, but carries a mortality rate between 25 and 50 percent when it does occur. Understanding who’s at risk and what symptoms to watch for makes this complication largely preventable.
Why Metformin Can Cause Lactic Acid Buildup
Your cells normally produce energy by burning glucose with oxygen inside mitochondria, the tiny power plants in every cell. Metformin works partly by inhibiting one step in this process, a component of the mitochondrial energy chain called Complex I. When this step slows down, cells shift toward a backup energy pathway that doesn’t require oxygen but produces lactic acid as a byproduct.
At normal doses and in a healthy body, this extra lactic acid is no big deal. Your liver clears it efficiently, converting it back into usable fuel. The problem starts when something impairs your body’s ability to clear lactate fast enough: kidney disease, liver problems, severe dehydration, or an unusually high dose of metformin. When production outpaces clearance, lactic acid accumulates in the blood, drops your blood pH below its normal range, and triggers a cascade of organ dysfunction.
Who Is Most at Risk
The single biggest risk factor is impaired kidney function. Metformin is eliminated almost entirely through the kidneys, so when they aren’t working well, the drug builds up to dangerously high concentrations. Current guidelines from NICE and other organizations state that metformin should not be started or continued in patients with an eGFR below 30 (a measure of how well the kidneys filter blood). People with moderate kidney impairment (eGFR between 30 and 60) can often continue metformin at reduced doses, but need closer monitoring.
Other conditions that raise the risk include:
- Liver disease: The liver is the main organ responsible for clearing lactic acid, so impaired liver function removes a critical safety net.
- Heart failure: Poor circulation reduces oxygen delivery to tissues, pushing cells toward the oxygen-free energy pathway that generates more lactic acid.
- Heavy alcohol use: Both metformin and alcohol independently increase lactic acid levels. Together, they can overwhelm the body’s ability to clear it.
- Acute illness or dehydration: Any condition that causes sudden kidney stress, severe infection, or significant fluid loss can tip the balance. Surgery, sepsis, and severe vomiting or diarrhea are common triggers.
Metformin also accumulates inside cells over time, which means people who have been taking it for longer periods may have higher tissue concentrations even if their blood levels appear normal. This intracellular buildup is one reason MALA can be difficult to treat quickly.
Symptoms to Recognize
The symptoms of metformin-associated lactic acidosis are frustratingly nonspecific, which is part of what makes it dangerous. They overlap with common side effects of metformin itself, especially early on. The key warning signs include nausea, vomiting, loss of appetite, abdominal pain, and unusual thirst.
As the condition worsens, more distinctive symptoms appear. Rapid, deep breathing is one of the body’s attempts to blow off excess acid through the lungs. Altered consciousness, ranging from confusion and drowsiness to loss of responsiveness, signals that the acidosis is becoming severe. At this stage, blood pH can drop to life-threatening levels. One published case report documented survival at a blood pH of 6.8 and a lactate level of 29 mmol/L, far beyond the diagnostic threshold of pH below 7.35 and lactate above 5 mmol/L. That case was exceptional; most patients do not survive acidosis that extreme.
The progression from early gastrointestinal symptoms to severe acidosis can happen over hours to days. If you take metformin and develop persistent vomiting, deep labored breathing, or unusual confusion, especially during an illness or after a period of poor fluid intake, seek emergency care.
How It’s Diagnosed and Treated
Diagnosis relies on blood tests showing elevated lactate (above 5 mmol/L), low blood pH, and typically a high metformin level, though metformin levels aren’t always available quickly in emergency settings. Doctors also check for an elevated anion gap, a calculated value from basic blood chemistry that helps confirm the type of acidosis.
Treatment focuses on three priorities: stopping metformin immediately, supporting the body’s ability to clear lactic acid, and removing metformin from the bloodstream. For severe cases, dialysis is the most effective way to pull metformin out of the blood. However, because the drug concentrates inside cells, blood levels often rebound after a dialysis session ends as metformin redistributes from tissues back into the circulation. This means some patients need prolonged or repeated dialysis sessions rather than a single treatment.
Supportive care in the ICU, including fluids and correction of other metabolic problems, is standard. Recovery depends heavily on how quickly treatment begins and whether the underlying trigger (kidney injury, infection, dehydration) can be reversed.
Contrast Dye and Metformin: The 48-Hour Rule
If you take metformin and need a CT scan or other imaging procedure that uses iodinated contrast dye, your doctor may ask you to temporarily stop the medication. The concern isn’t that contrast dye interacts with metformin directly. Rather, contrast dye can temporarily stress the kidneys, and if kidney function dips, metformin clearance slows, raising the risk of lactic acidosis.
Guidelines vary somewhat by organization, but the general approach is straightforward. If your kidney function is normal (eGFR above 60), most current guidelines say there’s no need to stop metformin for a standard IV contrast procedure. If your eGFR is between 30 and 60, some guidelines recommend pausing metformin on the day of the procedure and waiting 48 hours before restarting, with a kidney function check in between. If your eGFR is below 30, metformin should be held and only restarted after kidney function is confirmed to be stable. For procedures involving contrast injected directly into arteries, the rules are generally stricter regardless of kidney function.
Putting the Risk in Perspective
Despite its severity when it occurs, MALA is genuinely rare among the tens of millions of people taking metformin worldwide. The incidence of fewer than 10 cases per 100,000 patient-years means the vast majority of metformin users will never experience it. Metformin remains one of the safest and most effective diabetes medications available, with well-documented benefits for blood sugar control, cardiovascular health, and even longevity.
The cases that do occur almost always involve an identifiable risk factor: kidney disease that wasn’t caught or monitored, an acute illness that impaired kidney function, or continued use despite a clear contraindication. Routine kidney function testing, which most prescribers order at least annually for metformin users, is the single most important safeguard. Staying well-hydrated during illness, being cautious with alcohol, and alerting healthcare providers to your metformin use before any procedure involving contrast dye covers most of the remaining risk.